Clinical Trial Update: Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac

View source ↗

Summary

A completed clinical trial update assessing immunogenicity after two doses of the meningococcal outer membrane vesicle vaccine MenBVac.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenBVac (Meningococcal B vaccine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Vaccination | Status: COMPLETED